Continuous Glucose Monitoring Systems Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

The Continuous Glucose Monitoring Systems Market size is expected to grow at an annual average of 21% during 2021-2027. Continuous glucose monitoring (CGM) is one of the latest technological advances in diabetes management. The CGM system is a type of glucose monitoring device that functions by inserting a biosensor through the transdermal or subcutaneous route. The built-in sensor measures the glucose level in the interstitial fluid or blood and sends the information to the receiver/monitor using the transmitter to display the result. These systems play an essential role in diabetes management because they have several advantages over other glucose monitoring devices. Unlike traditional glucose monitors, these systems can periodically monitor glucose levels, which is important for preventing diabetes complications. CGMS technology also presented a roadmap for the most awaited, state-of-the-art closed-loop artificial/biological interest.

The following segmentation are covered in this report:

By Demographics

• Child Population (≤14 years)
• Adult Population (>14 years)
• By End User
• Diagnostics/Clinics
• ICUs
• Home Healthcare

 By Component

• Sensors 
• Transmitters & Receivers 
• Integrated Insulin Pumps

 Company Profile

• Abbott Laboratories
• Dexcom, Inc.
• Menarini Diagnostics s.r.l
• Echo Therapeutics, Inc.
• GlySens Incorporated
• Johnson and Johnson
• Medtronic Plc
• Senseonics Holdings, Inc.

Scope of the report

The research study analyses the Continuous Glucose Monitoring Systems Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Continuous Glucose Monitoring Systems Market Report

• What was the Continuous Glucose Monitoring Systems Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Continuous Glucose Monitoring Systems Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.